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Background: The relationship between intraocular pressure (IOP) changes and hemodialysis has been evaluated for
several decades. However, no report on an IOP rise in uveitis patients during hemodialysis has been previously
documented. This report describes the case of an uveitis patient with repetitive IOP spikes associated with severe
ocular pain during hemodialysis sessions, which resolved after glaucoma filtering surgery.
Case presentation: A 47-year-old male with diabetes and hypertension had complained of recurrent ocular pain in
the left eye during hemodialysis sessions. A slit-lamp examination showed diffuse corneal epithelial edema with
several white keratic precipitates and inflammatory cells (Grade 3+) in the anterior chamber of the left eye. No
visible neovascularization or synechiae were visible on the iris or angle. Topical glaucoma eye-drops and
intravenous mannitol before hemodialysis did not prevent subsequent painful IOP spikes in the left eye. At the end
of hemodialysis, IOP averaged ~40 mmHg. After trabeculectomy with mitomycin C in the left eye, his IOP stabilized
in the low-teens (range, 10–14 mmHg) and no painful IOP spikes occurred during hemodialysis over the first
postoperative year.
Conclusion: We present a case of recurrent painful IOP spikes during hemodialysis in a patient with unilateral
anterior uveitis unresponsive to conventional medical treatment prior to hemodialysis. To our knowledge, this is the
first case report of repetitive symptomatic IOP rise during hemodialysis in an uveitic glaucoma patient. This case
highlights the importance of the awareness of the possibility that IOP may rise intolerably during hemodialysis in
uveitis patients with a compromised outflow facility.
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Hemodialysis (HD) is an essential and common
treatment for end-stage renal disease, and the ocular
alterations associated with HD are wide ranging and
include refractive changes, central corneal thickness
changes, retinal nerve fiber layer thickness changes,
and changes in intraocular pressure (IOP) [1-3]. The
relationship between IOP changes and HD has been
evaluated for several decades, and whereas some
authors have found that HD does not affect IOP, others
have concluded that it increases or decreases IOP [4].* Correspondence: sccha@yumail.ac.kr
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reproduction in any medium, provided the orSome have reported a significant rise in IOP during
HD in eyes with a compromised aqueous outflow facility,
such as, in eyes with narrow angles [5], neovascular glau-
coma [6], or exfoliative glaucoma [7]. However, no report
on an IOP rise in uveitis patients during HD has been
previously published. Here, we present the case of an
uveitis patient with repetitive IOP spikes associated
with severe ocular pain during HD sessions, which
resolved after glaucoma filtering surgery.
Case presentation
A 47-year-old male with diabetes and hypertension had
complained of recurrent ocular pain in his left eye during
HD sessions. He had a history of kidney transplantation
due to end-stage diabetic nephropathy seven years previ-
ously, but he had undergone regular HD three times weekly. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to this presentation, he had also undergone uncomplicated
phacovitrectomy with intraocular lens implantation at
another hospital, due to proliferative diabetic retinopathy in
both eyes. Recently, he had become aware of a dull pain
and blurred vision in his left eye during HD. His left IOP
had reached levels of up to 54 mmHg over three weeks at a
local eye clinic. Accordingly, he was referred to our
glaucoma unit for management of uveitic glaucoma.
A slit-lamp examination showed diffuse corneal
epithelial edema with several white keratic precipitates
and inflammatory cells (Grade 3+) in the anterior chamber
of the left eye (Figure 1). No sectorial iris atrophy or iris
heterochromia developed during the follow-up period,
which suggests herpetic keratouveitis or Fuchs’ heterochro-
mic iridocyclitis. The gonioscopic findings showed a wide
open-angle status (Grade 4, using Shaffer’s classification)
and mild pigmentation (Grade 1 + ~2+) of the trabecular
meshwork without angle neovascularization or peripheral
anterior synechiae in both eyes. A more densely pigmented
trabecular meshwork was observed in the left eye than in
the right eye. Fundus examination revealed a clear vitreous,
a slightly pale optic disc, a cup to disc ratio of 0.8, and well-
applied photocoagulation scars in the left eye. The
unaffected fellow eye did not show abnormal findings
from the full ophthalmic examination, except for laser
photocoagulation scar due to diabetic retinopathy.
Serologic test for uveitis (include ESR, CRP, ANA, ANCA,
HLA-B27, and VDRL etc.) and radiologic findings
(chest X-ray and sacroiliac X-ray) were normal.Figure 1 Slit-lamp biomicroscopic findings in our uveitis patient. The
subsided (Grade 1+) with small whitish keratoprecipitates at the lower half
prednisolone acetate eye-drops. However, no visible angle or iris neovascuThe patient was initially treated with a fixed combination
of dorzolamide-timolol eyedrops (twice a day), brimonidine
eyedrops (twice a day), oral methazolamide (100 mg/day)
to control his IOP, and 1% prednisolone acetate every
two hours to manage inflammation. However, despite
the glaucoma medications, recurrent IOP elevation
with intolerable ocular pain occurred in the left eye
about two hours after HD initiation forcing discontinuation
and was not relieved by intravenous mannitolization. These
events were subsequently repeated several times. Topical
glaucoma eye-drops and intravenous mannitol before HD
did not prevent subsequent painful IOP spikes in the left
eye. At the end of HD, IOP averaged ~40 mmHg
(range, 34–47). Accordingly, we decided on glaucoma
filtering surgery. After trabeculectomy with mitomycin C
in the left eye, his IOP stabilized in the low-teens (range,
10–14 mmHg) and no painful IOP spikes occurred during
HD over the first postoperative year (Figure 2). Further-
more, the patient did not develop again signs of uveitis
after the trabeculectomy during his hemodialysis.
Discussion
We describe a case of recurrent painful IOP rise occurring
about two hours after initiating HD in a patient with uveitis.
To the best of our knowledge, this is the first case report of
repetitive symptomatic IOP rise during HD in an uveitic
glaucoma patient. Reports about IOP fluctuation during
HD can be divided into three categories [4]; those that
reported an IOP increase or decrease, and those reporting
no change.slit-lamp examination showed that inflammatory cellular reaction had
of the cornea (white arrow) 2 weeks after initiating topical 1%
larization was observed.
Figure 2 Intraocular pressure fluctuation after hemodialysis in our uveitis patient. *HD = Presenting IOP immediately after hemodialysis;
†Post-HD = Presenting IOP at one day after hemodialysis; #POD = Postoperative day. The mean IOP difference of the left eye before and after
hemodialysis was 25 mm Hg, and this difference was statistically significant. Postoperatively, IOP remained stable in the normal range
without medication.
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a rapid fall in plasma osmolarity, resulting in an osmolar
gradient between plasma and ocular tissue, causing water
movement into tissue, increased aqueous production, and
consequent IOP elevation [4]. Burn [8] provided a similar
explanation and described it as being analogous to cerebral
edema in disequilibrium syndrome. This mechanism was
further supported by Ghaffariyeh et al. [9] who noted high
vitreous urea rebound in a glaucoma patient with increased
IOP during HD.
Then, why do IOP changes occur immediately after HD
in uveitis patients and what is the clinical importance
of these changes? It is possible that the compensatory
mechanism of aqueous humor drainage is defective in
uveitis patients. In particular, aqueous outflow might
be reduced due to an increase in aqueous viscosity
caused by inflammatory products and various cyto-
kines, swelling or dysfunction of the trabecular mesh-
work, remodeling of the extracellular matrix, the
obliteration of outflow channels, or synechial closure
[10]. Tawara et al. [5] reported a remarkable increase
in IOP during HD in eyes with impaired aqueous
outflow as compared with eyes with normal aqueous
outflow. Furthermore, Yoon et al. [11] reported that
eyes with a pre-existing outflow obstruction had ahigh risk of IOP spikes during HD during the early
postvitrectomy period.
Besides the compromised outflow facility, Rever et al.
[12] reported that the anterior chamber depth decreased
significantly during the HD. Moreover, Jaeger et al. [13]
cited patients with narrow angles by gonioscopy who
experienced an IOP rise during HD. In this context,
gonioscopy is thought to be essential to the accurate
diagnosis of IOP spikes related to HD.
A wide variety of inflammatory diseases are associated
with ocular hypertension, such as Fuchs’ heterochromic
iridocyclitis, glaucomatocyclitic crisis, herpetic keratou-
veitis, sarcoidosis, rheumatoid arthritis, and syphilis [14].
Therefore, careful patient evaluation is essential for ac-
curate diagnosis and understanding of the pathogenesis
of glaucoma. Especially, specific signs, patterns of IOP
elevation, and past medical histories may also be evident
in certain types of uveitis [14]. In our patient, the slit-
lamp examination showed an intact corneal epithelium
and some keratic precipitates without sectorial iris
atrophy. Moreover, the gonioscopy revealed a wide
open-angle status and mild pigmentation of the trabecu-
lar meshwork without angle neovascularization or
synechiae. The results of the serologic test for syphilis,
the HLA-B27, and the chest radiology findings were
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anterior uveitis.
The prevention of marked IOP elevation during HD
might be achieved using a combination of IOP lowering
treatment and an appropriate HD technique [4], such as,
slower urea removal or high-flux HD, which are asso-
ciated with reduced urea rebound. Various medical treat-
ment modalities have been used to manage IOP rise
during HD, such as, topical and systemic carbonic anhy-
drase inhibitor, oral hyperosmotic agents, or intravenous
mannitolization. However, these drugs cause electrolyte
imbalances and metabolic acidosis, and although medi-
cation has been reported to be effective by some, in our
patient, medication prior to HD did not prevent IOP ele-
vation associated severe ocular pain. In addition, there
are a limited number of surgical reports, such as, argon
laser trabeculoplasty for exfoliative glaucoma [7], Ahmed
valve implantation for neovascular glaucoma [15], and
trabeculectomy for diabetic retinopathy [16] associated
with IOP elevation during HD.
In a previous study of Strvrou and Murray [17], they
reported that trabeculectomy might have a beneficial effect
on the course of uveitis. They suggested that the improved
aqueous outflow might allow the egression of inflammatory
mediators from the anterior chamber. Furthermore,
Weinreb [18] suggested that an anti-metabolite had
a beneficial effect on intraocular inflammation, and some
researchers [19] suggested that 5-FU might play a role in
the management of anterior uveitis. Thus, trabeculectomy
with adjunctive mitomycin C may theoretically improve
uveitis and yield a successful surgical outcome.
Conclusion
We present a case of recurrent painful IOP spikes during
HD in a patient with unilateral anterior uveitis unrespon-
sive to conventional medical treatment prior to HD. We
hope that this case report makes physicians aware of the
possibility of painful IOP elevation during HD in uveitis
patients with a compromised outflow facility.
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